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The Axin2-snail axis promotes bone
invasion by activating cancer-associated
fibroblasts in oral squamous cell carcinoma
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Abstract
Background: In bone-invasive oral squamous cell carcinoma (OSCC), cancer-associated fibroblasts (CAFs) infiltrate
into bony tissue ahead of OSCC cells. In the present study, we aimed to investigate the role of the Axin2-Snail axis
in the biological behaviour of CAFs and bone invasion in OSCC.
Methods: The clinicopathological significance of Axin2 and Snail expression was investigated by immunohistochemistry
in an OSCC cohort containing 217 tissue samples from patients with long-term follow-up. The influence of the Axin2-Snail
axis on the biological behaviour of OSCC cells and CAFs was further investigated both in vitro and in vivo.
Results: Axin2 expression was significantly associated with Snail expression, the desmoplasia status, and bone invasion in
patients with OSCC. In multivariate analysis, lymph node metastasis, desmoplasia, Axin2 expression, and Snail expression
were independent poor prognostic factors in our cohort. Consistent with these findings, OSCC cells demonstrated
attenuated oncogenic activity as well as decreased expression of Snail and various cytokines after Axin2 knockdown
in vitro. Among the related cytokines, C-C motif chemokine ligand 5 (CCL5) and interleukin 8 (IL8) demonstrated a strong
influence on the biological behaviour of CAFs in vitro. Moreover, both the desmoplastic reaction and osteolytic lesions in
the calvaria were predominantly decreased after Axin2 knockdown in OSCC cells in vivo using a BALB/c athymic nude
mouse xenograft model.
Conclusions: Oncogenic activities of the Axin2-Snail axis are not limited to the cancer cells themselves but rather extend
to CAFs via regulation of the cytokine-mediated cancer-stromal interaction, with further implications for bone invasion as
well as a poor prognosis in OSCC.
Keywords: Axin2, Snail, Cytokine, Cancer-stroma crosstalk, CAFs, Bone invasion, Prognosis, OSCC
Background
Oral squamous cell carcinoma (OSCC) is the most com-
mon histological type of oral cancer. OSCC cells often
penetrate underlying bone, and 12–56% of patients with
OSCC present with bone invasion [1]. According to the
American Joint Committee on Cancer (AJCC) classifica-
tion, the presence of bone invasion can upstage this type
of cancer regardless of tumour size because bone invasion
is a major poor prognostic indicator of OSCC [2–4]. How-
ever, the molecular mechanism underlying the invasion of
adjacent bone by OSCC is not fully understood.
Desmoplasia refers to the growth of excessive stromal
tissue around tumours, and fibroblasts located in this
stromal tissue, termed cancer-associated fibroblasts
(CAFs), are key players in the cancer stroma. The critical
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: lingjq@mail.sysu.edu.cn; zhangxianglan@yuhs.ac
†Yin-Zhe An and Eunae Cho contributed equally to this work.
1Key laboratory of Oral Medicine, Guangzhou Institute of Oral Disease,
Affiliated Stomatology Hospital of Guangzhou Medical University,
Guangzhou, Guangdong, China
4Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul,
Republic of Korea
Full list of author information is available at the end of the article
An et al. BMC Cancer          (2020) 20:987 
https://doi.org/10.1186/s12885-020-07495-9
roles of CAFs have been investigated recently in various
types of cancer [5–8]. CAFs promote angiogenesis via
the production of pro-angiogenic factors such as fibro-
blast growth factor 2 (FGF2) and vascular endothelial
growth factor A (VEGFA) and contribute to immune
surveillance in tumour cells by recruiting immunosup-
pressive cells such as myeloid-derived suppressor cells
(MDSCs) and M2 macrophages [9–11]. Moreover, CAF-
derived hepatocyte growth factor (HGF), stromal cell-
derived factor 1 (SDF1), and transforming growth factor
beta (TGF-β) promote the proliferation, invasion, and
metastasis of cancer cells by activating various signalling
pathways, such as the MAPK and PI3K/AKT pathways,
as well as the TGF-β/SMAD pathway [12–14]. In bone-
invasive OSCC, an abundant population of stromal cells
intervenes between OSCC cells and damaged bony tis-
sue. In particular, alpha-smooth muscle actin (α-SMA)-
positive CAFs, a major component of the cancer-related
stroma, have been shown to infiltrate into bony tissue
ahead of OSCC cells [15]. The biological characteristics
of CAFs may be important in the pathogenesis of bone
invasion in OSCC.
CAFs demonstrate heterogeneity in tumour tissues. In
pancreatic adenocarcinomas, for example, CAFs display
two distinct populations, myofibroblasts and inflamma-
tory fibroblasts, while in breast cancer, four different
populations of CAFs are observed, including those re-
lated to immune escape [16, 17]. Moreover, studies on
various cancers, including OSCC, have revealed the pres-
ence of a senescence-associated secretory phenotype of
CAFs that can secrete various cytokines and thereby in-
fluence the tumour microenvironment [18–20]. The
stromal role may differ according to the particular popu-
lation of CAFs.
The production as well as transdifferentiation of CAFs
may be regulated by cancer-stromal crosstalk. Some
tumour-derived factors, particularly proinflammatory
cytokines, trigger cancer-stromal crosstalk and further
influence multifaceted signalling pathways responsible
for cancer progression, thereby promoting the formation
of a favourable microenvironment for tumour cell sur-
vival, growth, and invasion [21, 22]. Recently, therefore,
CAFs have become regarded as a potential target to in-
crease the therapeutic efficacy of the treatment of various
cancers with desmoplastic features [23]. Accordingly, tar-
geting the key genetic factors involved in the desmoplastic
reaction in cancers may enable therapeutic advances for
patients resistant to current anti-cancer therapy.
Epithelial to mesenchymal transition (EMT) is medi-
ated by local activation of the canonical Wnt signalling
pathway in various types of cancer and promotes cell in-
vasion and metastasis during cancer progression by si-
lencing epithelial traits and inducing mesenchymal
phenotypes [24]. On the invasive front, cancer cells are
exposed to the extracellular matrix and can thereby par-
ticipate in cancer-stromal crosstalk. Snail, a zinc-finger
transcription factor, is primarily known as a transcrip-
tional repressor that mediates EMT via the repression of
E-cadherin transcription [25–27]. Recently, increasing
evidence has demonstrated that Snail-mediated transac-
tivation can remodel the tumour microenvironment dur-
ing EMT progression. The transcription of multiple
proinflammatory cytokines, such as C-C motif chemo-
kine ligand (CCL) 2 and CCL5, is activated by Snail
transactivation [28, 29]. Moreover, Snail can also directly
activate interleukin (IL) 8 transcription by binding to the
E3/E4 E-boxes [30]. In addition, Snail activates TGF-β
signalling pathway-related proteins, such as connective
tissue growth factor, secreted protein acidic and rich in
cysteine, fibronectin 1, and transgelin, which are involved
in fibrosis in various organs. Axis inhibition protein 2
(Axin2), a scaffolding protein of glycogen synthase kinase
3 (GSK-3), promotes cancer cell invasion and metastasis
in various types of malignancies by inhibiting GSK-3-
mediated Snail degradation [25, 31]. Axin2-mediated Snail
stabilization may contribute to cancer-stromal crosstalk
and thereby may influence cancer prognosis.
In the present study, the association between Axin2
expression and various clinicopathological factors, in-
cluding the desmoplasia status as well as bone invasion,
was investigated in patients with OSCC. The influence
of Axin2 expression on the biological behaviour of CAFs
was also investigated in vitro and in vivo with the aim of
identifying the possible role of Axin2 expression in the
pathogenesis of OSCC.
Methods
Patients in the OSCC cohort
In this study, we retrospectively reviewed the archived
files of patients with OSCC at Dental Hospital, Yonsei
University Medical Center, Seoul, Korea, from 1999 to
2017. Of the 432 patients reviewed, 217 with OSCC oc-
curring in lesion sites that might involve the maxilla and/
or the mandible were included in the present study. Of
these 217 patients in the OSCC cohort, 123 (56.7%) had
been determined during follow-up to have bone invasion,
while no bone invasion had been found in the other 94
(43.3%) patients (Fig. 1). The clinicopathological charac-
teristics of the patients in the OSCC cohort are shown in
Table 1. This study was approved by the Institutional Re-
view Board for Bioethics of the Yonsei University College
of Dentistry (IRB 2–2017-0006 and 2–2019-0050).
Immunochemical staining
The protein expression of α-SMA, vimentin, CD31,
Axin2, and Snail in cells and tissue samples was deter-
mined by immunochemical staining. Details on the pro-
cedures and scoring methods of immunochemical
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staining are described in the Supplementary Materials
and Methods.
Histomorphometry
As described in a previous study, the desmoplastic reaction
status was evaluated according to the ratio of the area of the
tumour-associated stroma to that of the whole tumour tissue
[32]. Histologic images were obtained using the light micro-
scope (Olympus BX53®, Tokyo, Japan) with an attached
digital camera (DP27®, Japan) and Olympus cellSens™ Entry
software. The subjected areas were measured on haematoxy-
lin and eosin-stained OSCC tumour tissue sections with
ImageJ software. The desmoplasia status was further divided
into two groups according to the calculated ratio:
high (ratio ≥ 1) and low desmoplastic (ratio < 1) reaction.
Cell lines
Two kinds of CAFs (CAF1 and CAF2) and two OSCC
cell lines (CA9–22 and HSC-2) were used in this study.
Details on the procedures of cell culture and the estab-
lishment of Axin2-knockdown OSCC cells are described
in the Supplementary Materials and Methods.
Recombinant proteins
All of the human recombinant proteins (CCL2, CCL5,
and IL8) were purchased from R&D Systems (Minneap-
olis, MN, USA).
Proliferation assay
To investigate the proliferative ability of each group of
cells, OSCC cells (1 × 105 /well) and CAFs (5 × 104 /well)
were seeded into 6-well plates at approximately 30%
confluency. The number of cells was counted after try-
pan blue staining at each indicated time point.
Fig. 1 Flow diagram of sample selection and enrolment for patients
with OSCC
Table 1 Clinicopathological characteristics of 217 OSCC patients
Clinicopathological variables No. of patients (%)
Total cases 217
Age, years
Median age (range) 61 (27–85)
≤ 61 113 (52.1)


































WD well differenciated, MD moderately differentiated, PD poorly differentiated
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Wound healing and invasion assays
Cell motility and invasion ability were determined for
each group of cells using wound healing and Matrigel
invasion assays, respectively. Details on the procedures
of wound healing and invasion assays are described in
the Supplementary Materials and Methods.
Quantitative reverse transcription polymerase chain
reaction (RT-PCR)
Quantitative RT-PCR was performed to determine the
mRNA expression of IL8, CCL2, CCL5, matrix metallo-
proteinase (MMP)-2, MMP-9, and Ki67 in the cell lines.
Details on the RT-PCR procedure are described in the
Supplementary Materials and Methods.
Nude mouse xenograft model
The animal studies were performed according to experi-
mental protocols approved by the Animal Ethics Commit-
tee of the Yonsei University College of Dentistry. Twenty
female 5-week-old BALB/c athymic nude mice (Central La-
boratory Animal Inc., Seoul, Korea) were housed in laminar
flow cabinets under specific pathogen-free conditions.
CAFs are derived from resident fibroblasts, bone
marrow-derived mesenchymal precursor cells, adipo-
cytes, endothelial cells, and EMT, endothelial to mesen-
chymal transition (EndMT), and various cytokines are
implicated in the production of CAFs [33]. As well-
known EMT genes, those involved in the Axin2-Snail
axis may also contribute to the production of CAFs. In
this study, we aimed to investigate the influence of
Axin2 knockdown on both the production and biological
behaviour of CAFs using a xenograft mouse model.
All of the mice were randomized into four groups
(n = 5 per group), and a total of 1 × 106 HSC-2Mock,
HSC-2△Axin2, CA9–22Mock, and CA9–22△Axin2 cells were
subcutaneously injected into the calvaria of the mice.
The length and width of the tumour nodules were mea-
sured every 3 days, and the size of the tumours was cal-
culated with the following formula: width2 × length× 1/2.
We have acquired micro-computed tomography (micro-
CT) images with Skyscan 1173 (Bruker-microCT,
Kontich, Beigium) and reconstructed those images with
Nrecon software. All of the mice were sacrificed after
9 weeks by CO2 asphyxiation.
Statistical analysis
The association between protein expression and clinico-
pathological variables was analysed using the chi-square
test. The Mann-Whitney U-test was used to compare
proliferation, migration, invasion, and tumorigenesis be-
tween groups. SPSS software version 23.0 (SPSS Inc.,
Chicago, IL, USA) was used for statistical analysis, and a
p-value less than 0.05 was considered statistically
significant.
Results
Clinicopathological significance of Axin2 and snail
expression in patients with OSCC
In the present study, Axin2 expression was found in the
cytoplasm of cancer cells in 168 (77.4%) patients with
OSCC, and immunoreactivity against Axin2 was high in
101 (high-Axin2, 46.5%) OSCC tissue samples and low
in 116 (low-Axin2, 53.5%). Cancer cells demonstrated
cytoplasmic and nuclear Snail expression in 186 (85.7%)
patients with OSCC, and immunoreactivity against Snail
was high in 107 (high Snail, 49.3%) OSCC tissue samples
and low in 110 (low Snail, 50.7%). A significant associ-
ation was found between Axin2 expression and Snail ex-
pression in patients with OSCC (p = 0.006) (Fig. 2a).
Both high Axin2 expression and high Snail expression
showed a significant association with T stage (p < 0.001
and p = 0.031), lymph node metastasis (both p < 0.001),
vascular invasion (p = 0.01 and p = 0.019), and bone inva-
sion (p < 0.001 and p = 0.028) in the present study. The
sex differences in the prognosis of OSCC patients re-
main controversial [34]. In our study, we did not find a
significant association between sex and the prognosis of
OSCC. Moreover, there was no significant association
between sex and Axin2 or Snail expression in our co-
hort. The current edition of the “Classification of Head
and Neck Tumors” suggests three histological grades for
conventional OSCC: well-, moderately, and poorly differ-
entiated variant, in spite the fact that they remark grad-
ing as ‘Grading alone does not correlate well with
prognosis’ [35]. Consistent with this, we did not find a
significant association between histological grade and
prognosis in our cohort. High Axin2 expression showed
a tendency to gradually increase from well-differentiated
OSCC (37.1%, 13/35) to moderately differentiated OSCC
(47.7%, 71/149) to poorly differentiated OSCC (51.5%,
17/33). However, there were no significant differences
between the groups (Table 2).
Moreover, patients with high Axin2 or high Snail ex-
pression demonstrated increased vessel density (p <
0.001 and p = 0.002) and a higher desmoplastic reaction
(both p < 0.001) than patients with low Axin2 or low
Snail expression in our cohort (Fig. 2b and c). To iden-
tify the risk factors for the prognosis of OSCC, multi-
variate analysis was performed in 179 patients who were
followed up for more than 5 years. The results showed
that when using age, sex, lesion site, T stage, lymph
node metastasis, histologic grade, vascular invasion, peri-
neural invasion, bone invasion, desmoplasia status,
angiogenesis status, Axin2 expression, and Snail expres-
sion as cofactors, lymph node metastasis, desmoplasia
status, Axin2 expression, and Snail expression were in-
dependent risk factors for OSCC prognosis, with hazard
ratios of 3.424 (95% confidence interval, 1.466–7.998;
p = 0.004), 2.491 (95% confidence interval, 1.240–5.004;
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p = 0.01), 2.488 (95% confidence interval, 1.358–4.559;
p = 0.003), and 1.984 (95% confidence interval, 1.097–
3.588; p = 0.024), respectively (Table 3).
Axin2 knockdown had a strong influence on the
biological behaviour of OSCC cells
Consistent with the results of a previous study [25], we
found that Snail expression was predominantly decreased
in both CA9–22△Axin2 and HSC-2△Axin2 cells compared to
the related control cells (Supplementary Fig. A, i and iv).
Proliferative ability was significantly reduced after Axin2
knockdown in both CA9–22 and HSC-2 cells. Compared
with CA9–22Mock cells, decreases of 1.4-, 2.1-, and 2.2-fold
in cell number were found in CA9–22△Axin2 cells after 24 h,
48 h, and 72 h of culture (all p = 0.008). Similarly, HSC-
2△Axin2 cells also showed decreases of 1.4-, 1.6-, and 2.3-fold
in number compared to HSC-2Mock cells (all p = 0.008)
(Supplementary Fig. A, ii and v). Likewise, Ki67 expression
was significantly decreased in Axin2-knockdown cells com-
pared to both HSC-2 and CA9–22 control cells (both p =
0.002) (Supplementary Fig. A, iii and vi). In addition, cell
motility was decreased 1.5- and 1.8-fold, respectively, in
Axin2-knockdown cells compared to CA9–22 and HSC-2
control cells (both p = 0.002) (Supplementary Fig. B, i-iv).
Moreover, 2.3- and 1.6-fold decreases in the numbers of in-
vading cells were found in Axin2-knockdown cells com-
pared to CA9–22 and HSC-2 control cells, respectively
(both p = 0.002). Axin2 may have oncogenic activity in
OSCC cells (Supplementary Fig. C, i-iv). Interestingly, com-
pared to the related control cells, the expression of Snail-
Fig. 2 Clinicopathological significance of Axin2 and Snail expression in patients with OSCC. a Representative expression patterns for Axin2 and
Snail in OSCC tissue samples (original magnification, × 400; scale bar, 25 μm) (i). Axin2 expression and Snail expression are significantly correlated
in OSCC tissues (ii). b Association between microvessel density and the expression of Axin2 and Snail in OSCC tissues: Example of a hot spot in
OSCC tissues (original magnification, × 200; scale bar, 50 μm) (i). Microvessel density is significantly associated with Axin2 and Snail expression (ii-
iii). c Association between the desmoplastic reaction and the expression of Axin2 and Snail in OSCC tissues: representative histological patterns of
low and high desmoplastic reactions in OSCC tissues (i). The desmoplastic reaction is significantly associated with Axin2 and Snail expression
(original magnification, × 100; scale bar, 100 μm) (ii-iii) (* p < 0.05) (T: tumour, S: stroma, B: bone)
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related cytokines IL8, CCL2, and CCL5 was 3.5-fold, 2.8-
fold, and 3.3-fold decreased, respectively, in CA9–22△Axin2
cells (all p = 0.002) and 2.6-fold, 1.8-fold, and 1.5-fold de-
creased, respectively, in HSC-2△Axin2 cells (all p = 0.002)
(Supplementary Fig. D, i-ii).
Cytokines related to the Axin2-snail axis exert strong
influences on the biological behaviour of CAFs
To evaluate the effect of these cytokines on the biological
behaviour of CAFs, both CAF1 and CAF2 cells were treated
with different doses (0, 2, 5, and 10 ng/ml) of human recom-
binant proteins (IL8, CCL2, and CCL5), after which the pro-
liferation and invasion abilities of CAFs in each group were
comparatively investigated. A strong influence of IL8 or
CCL5 on the biological behaviour of CAFs was found at a
dose of 2 ng/ml in the present study. CAF1 cells showed in-
creases of 2.5- and 2.0-fold in the numbers of cells after
treatment with 2 ng/ml IL8 or CCL5, respectively, compared
to untreated control cells (both p= 0.002). Similar results
were obtained using CAF2, with IL8 or CCL5 treatment
leading to increases in cell numbers (both p = 0.002). No sig-
nificant differences were observed in the proliferative ability
of CAFs after CCL2 treatment in this study (Fig. 3b, i-ii).
We also found that the invasion ability of CAF1 and
CAF2 cells was 2.2- and 2.3-fold increased, respectively,
after IL8 (2 ng/ml) treatment compared to untreated
Table 2 Clinicopathological significance of Axin2 and Snail expression in 217 OSCC patients
Variables Total Axin2 P Snail P
Low High Low High
Age
≤ 61 113 65 (57.5) 48 (42.5) 0.211 60 (53.1) 53 (46.9) 0.46
> 61 104 51 (49.0) 53 (51.0) 50 (48.1) 54 (51.9)
Sex
Male 141 69 (48.9) 72 (51.1) 0.069 74 (52.5) 67 (47.5) 0.472
Female 76 47 (61.8) 29 (38.2) 36 (47.4) 40 (52.6)
Site
Mandible 112 66 (58.9) 46 (41.1) 0.173 60 (53.6) 52 (46.4) 0.681
Maxilla 67 34 (50.7) 33 (49.3) 32 (47.8) 35 (52.2)
RMT 38 16 (42.1) 22 (57.9) 18 (47.4) 20 (52.6)
T stage
T1-T2 72 51 (70.8) 21 (29.2) < 0.001 44 (61.1) 28 (38.9) 0.031
T3-T4 145 65 (44.8) 80 (55.2) 66 (45.5) 79 (54.5)
N stage
Nx 48 31 (64.6) 17 (35.4) < 0.001 29 (60.4) 19 (39.6) < 0.001
N0 95 62 (65.3) 33 (34.7) 57 (60.0) 38 (40.0)
N1–3 74 23 (31.1) 51 (68.9) 24 (32.4) 50 (67.6)
Histologic grade
WD 35 22 (62.9) 13 (37.1) 0.439 19 (54.3) 16 (45.7) 0.565
MD 149 78 (52.3) 71 (47.7) 77 (51.7) 72 (48.3)
PD 33 16 (48.5) 17 (51.5) 14 (42.4) 19 (57.6)
Perineural invasion
Negative 202 110 (54.5) 92 (45.5) 0.279 105 (52.0) 97 (48.0) 0.163
Postive 15 6 (40.0) 9 (60.0) 5 (33.3) 10 (66.7)
Vascular invasion
Negative 192 109 (56.8) 83 (43.2) 0.01 103 (53.6) 89 (46.4) 0.019
Postive 25 7 (28.0) 18 (72.0) 7 (28.0) 18 (72.0)
Bone invasion
Negative 94 63 (67.0) 31 (33.0) < 0.001 56 (59.6) 38 (40.4) 0.028
Postive 123 53 (43.1) 70 (56.9) 54 (43.9) 69 (56.1)
WD well differenciated, MD moderately differentiated, PD poorly differentiated
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control cells (both p = 0.002). Consistent with these find-
ings, MMP-2 expression was 2.3-fold and 2.2-fold in-
creased after IL8 (2 ng/ml) treatment in both CAF1 and
CAF2 cells, respectively, compared to untreated control
cells (both p = 0.002). No significant difference was
found in MMP-9 expression in CAFs after IL8 treatment
in our study (Fig. 3c, i-vi).
Tumour progression and bone invasion depend on Axin2
expression in tumour cells in vivo
As shown in Fig. 4, tumour volume was significantly de-
creased in mice injected with Axin2-knockdown cells
compared to both CA9–22 and HSC-2 control cells (A,
i-ii). In micro-CT imaging analysis, extensive osteolytic
lesions were observed in the calvaria from CA9–22Mock
or HSC-2Mock cell-bearing mice compared to the related
Axin2-knockdown cell-bearing mice (B, i-ii). Moreover,
in the tissue sections, the area of the tumour-associated
stroma was predominantly increased at the tumour-bone
interface in CA9–22Mock or HSC-2Mock cell-bearing mice
compared to the related Axin2-knockdown cell-bearing
mice (C, i-ii).
Discussion
Although earlier studies focused on the inhibitory role
of Axin2 in the β-catenin degradation complex, recent
studies have implied that Axin2 contributes to onco-
genic progression. Increased expression of Axin2 was
found after the loss of adenomatous polyposis coli
(APC), a key tumour suppressor gene, in colorectal can-
cer, and the knockdown of Axin2 attenuated oncogenic
and Wnt signalling activities in cancer cells [36, 37]. The
GSK3 nuclear export function of the Axin2-mediated
abundance of nuclear Snail and β-catenin is also a sign
of the oncogenic activity of Axin2 [25]. In our previous
study, we found that Axin2 expression showed a positive
correlation with Snail expression, and increased expres-
sion of both Axin2 and Snail was closely associated with
the malignant transformation of oral leukoplakia [38].
Consistent with these findings, high Axin2 expression
and high Snail expression are significantly correlated in
OSCC tissues. Moreover, we found that both Axin2
expression and Snail expression were significantly re-
lated to a poor prognosis and serve as poor prognostic
indicators of OSCC, including bone invasion in OSCC.
Consistent with these results, Axin2-knockdown cells
showed decreased Snail expression and attenuated onco-
genic activities compared to control cells. Axin2 may be
implicated in OSCC pathogenesis as an oncogene.
Desmoplasia is a typical sign of aggressiveness in vari-
ous types of cancer, including OSCC [15, 39]. Some in-
vestigators have shown that an abundant desmoplastic
reaction is prominent in the cancer-bone interface of
OSCC with bone invasion, but an identifiable fibrous
stroma has been less frequently found in ameloblastoma,
a benign odontogenic epithelial tumour with features of
bone invasion [15]. In the present study, we also found
frequent desmoplastic reactions in OSCC tissues, espe-
cially in the area of bone invasion, and the desmoplasia
status was significantly associated with bone invasion in
patients with OSCC. Interestingly, both Axin2 expres-
sion and Snail expression were positively correlated with
the desmoplastic reaction in our cohort. Moreover, in
the mouse xenograft analysis, the stromal component of
tumour nodules as well as the osteolytic bone resorption
of mouse calvaria were predominantly decreased in the
group of cells with Axin2 knockdown compared to con-
trol cells. In addition, the expression of Snail-mediated
proinflammatory cytokines, such as IL8, CCL2, and
CCL5, was significantly decreased after Axin2 knock-
down in OSCC cells compared to control cells. Admit-
tedly, all of these cytokines are related to characteristics
Table 3 Prognostic impact of clinical variables and biomarkers
in multivariate Cox regression analysis in 179 OSCC patients
Hazard ratio (95% CI) p
Age 0.825 (0.482–1.410) 0.481
Sex 0.609 (0.339–1.093) 0.096
Lesion site
Mandible 1 0.235
Maxilla 0.618 (0.289–1.323) 0.215
RMT 1.206 (0.608–2.392) 0.591
T stage
T1 0.99
T2 0.989 (0.319–3.066) 0.985
T3 1.059 (0.119–9.453) 0.959
T4 1.157 (0.386–3.467) 0.795
N stage
Nx 0.014
N0 1.927 (1.016–3.655) 0.044
N1–3 3.424 (1.466–7.998) 0.004
Histologic grade
WD 1 0.435
MD 1.209 (0.592–2.467) 0.602
PD 1.665 (0.730–3.798) 0.226
Perineural invasion 0.850 (0.321–2.247) 0.743
Vascular invasion 1.036 (0.457–2.350) 0.933
Bone invasion 1.357 (0.572–3.219) 0.489
Desmoplasia 2.491 (1.240–5.004) 0.01
Angiogenesis 1.449 (0.860–2.441) 0.164
Axin2 2.488 (1.358–4.559) 0.003
Snail 1.984 (1.097–3.588) 0.024
WD well differenciated, MD moderately differentiated, PD poorly differentiated,
95% CI 95% confidence interval
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of aggressiveness by means of promoting the migration,
invasion, and metastatic abilities of cancer cells, includ-
ing those of OSCC, and are considered potential thera-
peutic targets of malignancies [40–44].
According to previous studies, all of these tumour-
derived cytokines also influence different types of cells
in the stromal component of tumours, such as CAFs,
endothelial cells, and inflammatory cells, and thereby
trigger multiple signalling pathways related to the malig-
nant progression of tumours. Both CCL2 and CCL5 me-
diate the infiltration of tumour-associated macrophages
and inhibit potential anti-tumour T-cell activities,
thereby controlling the populations of leukocytes at
tumour sites [43]. Moreover, distinct regulatory roles as
well as underlying molecular mechanisms performed by
CCL2 and IL8 in angiogenesis have been indicated by
some investigators. CCL2 enhances angiogenic activity
either by directly inducing endothelial cell retraction or
by the CCL2-induced release of angiogenic factors such
as VEGFA [45, 46]. IL8 promotes the invasion ability of
endothelial cells via increased expression of MMP-2 and
MMP-9 in endothelial cells [47]. Moreover, IL8 pro-
motes the proliferation and tube formation of endothe-
lial cells by activating extracellular signal-regulated
protein kinase 1/2 (Erk1/2) during interaction with
CXCR2 in endothelial cells [48]. In the present study, we
found that CD31-positive vessel density was significantly
associated with Axin2 and Snail expression in patients
with OSCC. In OSCC, the Axin2-Snail axis may also
mediate angiogenic responses via the control of related
cytokines.
A previous study demonstrated that 12 different types
of chemokine receptors were found in oral fibroblasts,
including CXCR1, CXCR2, and CCR3 [49]. In the
Fig. 3 Cytokines related to the Axin2-Snail axis exert strong influences on the biological behaviour of cancer-associated fibroblasts (CAFs) in vitro.
a CAF identities were verified based on the expression of vimentin and α-SMA. b Proliferation was significantly increased after CCL5 or IL8
treatment in both CAF1 and CAF2 cells (i & ii). c Invasion ability and MMP-2 expression were significantly increased after IL8 treatment in both
CAF1 (i-iii) and CAF2 (iv-vi) cells (original magnification, × 100; scale bar, 100 μm) (* p < 0.05)
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present study, we found that both CCL5 and IL8 have a
strong influence on the biological behaviour of CAFs.
These cytokines may influence CAFs by binding to related
receptors. All of these findings imply that the Axin2-Snail
axis mediates a diffuse desmoplastic reaction in OSCC by
controlling inflammation-stromal crosstalk.
In the present study, recombinant IL8 increased the
invasion ability of CAFs in vitro. In various types of can-
cer tissues, IL8 participates in degradation of the extra-
cellular matrix by promoting the expression of MMP-2
and MMP-9 in cancer cells [50–53]. According to an
analysis of a public data base, MMP-9 acts in a context-
dependent manner in different types of cancer [54]. In
this study, no significant difference was found in MMP-
9 expression in CAFs after IL8 treatment. In the present
study, we also found that MMP-2 expression was signifi-
cantly increased in CAFs after IL8 treatment. A previous
study showed that MMP-2 was expressed primarily in
the fibroblasts of mouse lung tumours and concluded
that CAFs were the main producer of MMP-2 [55].
MMPs can directly destroy the bone matrix; thus, IL8-
mediated MMP-2 overexpression may be one of the
underlying molecular mechanisms of CAFs infiltration
into bony tissue ahead of OSCC cells in patients with
high Axin2 expression.
Conclusions
Consistent with previous observations in other cancers
[25], our results imply that the Axin2-Snail axis is a poor
prognostic indicator of OSCC. We also found that the
oncogenic activities of the Axin2-Snail axis are not lim-
ited to the cancer cells themselves but rather extend to
cancer-associated stromal cells such as endothelial cells
and CAFs via regulation of the cytokine-mediated
Fig. 4 Tumour progression and bone invasion depend on Axin2 expression in tumour cells in vivo. a Tumour volume was predominantly decreased in
mice injected with Axin2-knockdown cells compared to both HSC-2 (i) and CA9–22 control cells (ii). b In micro-CT imaging analysis revealed extensive
osteolytic lesions in the calvaria from HSC-2Mock or CA9–22Mock cell-bearing mice compared to the related Axin2-knockdown cell-bearing mice (i-ii). c The
area of the tumour-associated stroma was predominantly increased at the tumour-bone interface in CA9–22Mock or HSC-2Mock cell-bearing mice compared
to the related Axin2-knockdown cell-bearing mice (i-ii) (original magnification, × 200; scale bar, 50 μm, T: tumour, S: stroma, B: Bone) (* p< 0.05)
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cancer-stromal interaction, thereby promoting active
desmoplastic reactions as well as bone invasion in
OSCC. The Axin2-Snail axis may serve as a novel diag-
nostic and therapeutic target in bone-invasive OSCC.
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